Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von B R Sevanthini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sankalp India Foundation, Bangalore, India. Hauptthemen laut MEDLINE: Hydroxyurea, beta-Thalassemia, Blood Transfusion, Antisickling Agents. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Clinical outcomes of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with β-thalassaemia syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sankalp India Foundation, Bangalore, India.
- Jagriti InnoHealth Platforms Pvt. Ltd., Bangalore, India.
- Cure2Children Foundation, Florence, Italy.
ORCID-Profile: Rajat Kumar Agarwal
Zitieren
APA
Sevanthini, B. R., Hegde, S., Sridhar, T., Trivedi, D., Reddy, M., Shah, V., Panchamia, V. M., Geetha, T., Vora, D., Pushpa, H., Agarwal, R. K., & Faulkner, L. (2025). Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes. British Journal of Haematology. https://doi.org/10.1111/bjh.70109
Vancouver
Sevanthini BR, Hegde S, Sridhar T, Trivedi D, Reddy M, Shah V, et al. Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes. British Journal of Haematology. 2025. doi:10.1111/bjh.70109
BibTeX
@article{Sevanthini2025,
author = {Sevanthini, B R and Hegde, Santhosh and Sridhar, Tejashree and Trivedi, Deepa and Reddy, Mohan and Shah, Vaibhav and Panchamia, Vidhi Mayur and Geetha, T and Vora, Dharmik and Pushpa, H and Agarwal, Rajat Kumar and Faulkner, Lawrence},
title = {Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70109}
}
EUVIMED